ENGINEERING MEDICINES TO IMPROVE PATIENT CARE Investors Event Details Viridian Therapeutics: VRDN-001 3 mg/kg Phase 2 Data in Active TED - January 2023 January 8, 2023 8:00 AM EST to January 8, 2023 12:00 AM EST Supporting Materials Viridian Therapeutics: VRDN-001 3 mg/kg Phase 2 Data in Active TED - January 2023 2.1 MB
Viridian Therapeutics: VRDN-001 3 mg/kg Phase 2 Data in Active TED - January 2023 January 8, 2023 8:00 AM EST to January 8, 2023 12:00 AM EST Supporting Materials Viridian Therapeutics: VRDN-001 3 mg/kg Phase 2 Data in Active TED - January 2023 2.1 MB